Procter & Gamble Co stock: What you should know now
The article provides an in-depth analysis of Procter & Gamble Co (PG) stock, highlighting its stable business model, consistent dividends, and defensive play in uncertain markets. It covers recent financial performance, market position compared to peers, and analyst ratings from major banks, alongside key investment risks. The report aims to help global investors decide if PG is a suitable addition to their portfolios, emphasizing its appeal for income and stability-seeking investors.
Toothpaste Buyers Could Cash In After $2.9M Settlement: Here's How
Tom's of Maine has agreed to a $2.9 million settlement following a class-action lawsuit alleging deceptive practices in its toothpaste manufacturing and marketing. Customers who purchased Tom's toothpaste between November 21, 2020, and March 6, 2026, are eligible to file a claim. Payouts can range from the average retail price for one product without proof of purchase, to a full refund for up to three products with proof.
UBS Group Cuts Colgate-Palmolive (NYSE:CL) Price Target to $98.00
UBS Group has lowered its price target for Colgate-Palmolive (NYSE:CL) to $98.00 from $100.00 but maintained a "buy" rating, suggesting a significant upside. Despite recent insider stock sales, large institutions have increased their holdings, with approximately 80% of the stock institutionally owned. The company recently reported strong earnings, beating analyst estimates for both EPS and revenue.
Did you buy this toothpaste? You may qualify for a cash payout.
Consumers who purchased Tom's of Maine toothpaste between November 21, 2020, and March 6, 2026, may be eligible for a cash payout from a class-action settlement. The lawsuit accused the company of deceptive marketing practices, which Tom's of Maine denies but has agreed to settle to avoid litigation costs. Claims must be filed by July 6, and payments will be distributed after a final court approval set for September 10.
Did you buy this toothpaste? You may qualify for a cash payout.
Consumers who purchased Tom's of Maine toothpaste products between November 21, 2020, and March 6, 2026, may be eligible for a cash payout from a class-action settlement. The lawsuit accused the company of deceptive practices, which Tom's of Maine denies. Claims must be filed by July 6, and a final approval hearing for the settlement is scheduled for September 10.
If you bought this popular toothpaste in the last 6 years, you could get money back
Tom's of Maine has reached a $2.9 million class action settlement regarding deceptive practices in its toothpaste manufacturing and marketing. Consumers who purchased Tom’s toothpaste between November 21, 2020, and March 6, 2026, may be eligible for compensation. Claims must be submitted by July 6, 2026, with or without proof of purchase, and a final approval hearing for the settlement is scheduled for September 10, 2026.
Understanding Momentum Shifts in (CL)
Colgate-Palmolive (CL) is experiencing neutral sentiment in the near term, which could moderate mid-term weakness. The article highlights an exceptional 33.6:1 risk-reward setup, targeting a 9.6% gain against 0.3% risk. AI models have generated three trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels based on multi-timeframe signal analysis.
Colgate-Palmolive Company (NYSE:CL) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
Seventeen brokerages have given Colgate-Palmolive (NYSE:CL) a "Moderate Buy" consensus rating, with an average 12-month price target of $95.19. The company recently beat Q4 earnings and revenue estimates and raised its quarterly dividend, now offering a 2.5% yield. However, company insiders have been significant sellers of the stock, offloading 184,683 shares worth $17.49 million over the past 90 days.
Tom’s of Maine Toothpaste $2.9M No Proof Settlement
Colgate-Palmolive Co. and Tom’s of Maine Inc. have agreed to a $2.9 million class action settlement for consumers who purchased Tom's of Maine toothpaste between November 21, 2020, and March 6, 2026. The lawsuits alleged deceptive practices regarding the manufacturing and marketing of the toothpaste. Eligible class members can claim cash refunds for up to three products, with options for claims both with and without proof of purchase.
Kimberly-Clark Has Fallen 33%. Is KMB Stock Finally a Buy?
Kimberly-Clark (KMB) stock has dropped 33.80% from its 52-week high, raising questions about whether it's undervalued or a value trap. While bulls point to strong free cash flow and a long dividend streak, bears highlight two major deals and commodity pressures. The article analyzes KMB's valuation compared to peers and discusses the potential upside and downside based on its acquisition of Kenvue and its joint venture with Suzano.
Can Procter & Gamble's Supply Chain Overhaul Withstand Volatility?
Procter & Gamble is implementing a "Supply Chain 3.0" overhaul, incorporating advanced analytics, AI, and digitalization to build a resilient and sustainable supply chain. This strategy aims to boost productivity, cut costs, and enhance margins by streamlining operations and leveraging technology. Despite ongoing external pressures, P&G's focus on productivity, innovation, and market expansion is expected to enable adaptation to evolving consumer trends and maintain competitiveness.
Tom's toothpaste at center of class-action settlement. See if you could be owed money
Customers who bought Tom's toothpaste products between November 21, 2020, and March 6, 2026, may be eligible for a payout from a $2.9 million class-action settlement. The lawsuit alleged "deceptive and misleading business practices" by the brand, a subsidiary of Colgate-Palmolive Company, stemming from FDA concerns about facility conditions. Claims can be submitted online or by mail by July 6, 2026, with proof of purchase potentially leading to a full refund.
Cidel Asset Management Inc. Has $23.80 Million Position in Colgate-Palmolive Company $CL
Cidel Asset Management Inc. has reported a $23.8 million position in Colgate-Palmolive Company (CL) as of its most recent SEC filing, despite trimming its stake by 4.3% in Q4. Colgate-Palmolive recently exceeded Q4 earnings expectations with $0.95 EPS and increased its quarterly dividend to $0.53, leading to an annualized payout of $2.12 with a 2.5% yield. The stock has received a "Moderate Buy" consensus rating from analysts, with a target price of $95.19, though some insiders have recently sold shares.
Colgate-Palmolive (India) stock: What you should know now for smart investing
This report provides an in-depth analysis of Colgate-Palmolive (India) for investors, highlighting its strong position in India's booming oral care market due to brand loyalty and tailored products for local tastes. It covers the company's business model, competitive edge, and key growth drivers from India's demographics and rising middle class, positioning it as a compelling pick for diversified portfolios. The article also discusses potential risks such as raw material inflation and increased competition, while noting positive analyst views and advising investors on whether to buy now based on risk tolerance and long-term trends.
Colgate-Palmolive (India) stock: What you should know now for smart investing
Colgate-Palmolive (India) is highlighted as a compelling investment due to its dominance in India's rapidly growing oral care market, strong brand loyalty, and effective local market strategies. The company benefits from India's rising incomes, urbanization, and increasing health awareness, offering stable cash flows and diversification for global portfolios. While risks like raw material inflation and competition exist, analysts view the stock favorably for its resilient demand and potential for long-term growth.
Deutsche Bank upgrades Colgate-Palmolive Company (CL) to buy, sees opportunity after selloff
Deutsche Bank has upgraded Colgate-Palmolive Company (CL) to a "buy" rating, citing an attractive opportunity following a recent selloff in the stock. The bank believes the current market conditions present a favorable entry point for investors.
Colgate Palmolive (CL) Valuation Check As Mixed Returns Contrast With Premium P/E Multiple
Colgate-Palmolive (CL) stock is currently priced at $85.14, showing mixed short-term returns but long-term compounding. While one narrative suggests it's 12.5% undervalued at a fair value of $97.26 due to expansion and premiumization of core products, the company's P/E ratio of 32x earnings is significantly higher than peers and industry averages, indicating valuation risk. Investors are encouraged to weigh these contrasting signals and review underlying data and warning signs before making investment decisions.
Aberdeen Group plc Sells 40,448 Shares of Colgate-Palmolive Company $CL
Aberdeen Group plc reduced its stake in Colgate-Palmolive Company (NYSE:CL) by 6.5% during the fourth quarter, selling 40,448 shares and leaving them with 579,469 shares valued at $45.79 million. Other institutional investors adjusted their positions, with some increasing and others initiating new stakes. Meanwhile, Colgate-Palmolive saw insider selling activity from its CFO and another insider, totaling over $10 million, though analysts largely maintain a "Moderate Buy" rating with an average target price of $95.19.
Colgate (NYSE: CL) director defers retainer into 266 stock units
Colgate-Palmolive director John P. Bilbrey acquired 266 shares of Common Stock as a compensation award, valued at $89.05 each. This transaction represents a deferral of a portion of his annual cash retainer into a stock unit account under the company's Deferred Compensation Plan for Non-Employee Directors. After this grant, Bilbrey directly holds 37,665 shares and indirectly holds an additional 4,719 shares through a trust.
Colgate-Palmolive (CL) director Norrington defers retainer into 294-share award
Colgate-Palmolive (CL) director Lorrie M. Norrington received an equity award of 294 shares of common stock, valued at $89.05 per share. This award is a result of deferring a portion of her annual cash retainer into a stock unit account. Following this transaction, Norrington's direct holdings in Colgate-Palmolive have increased to 40,160 shares.
Colgate-Palmolive (CL) director defers retainer into 210-share stock grant
Colgate-Palmolive director Brian Newman received a grant of 210 shares of Common Stock valued at $89.05 per share on April 1, 2026. This grant resulted from deferring a portion of his annual cash retainer into a stock unit account under the Deferred Compensation Plan for Non-Employee Directors. Following this transaction, Newman directly holds 5,534 shares of CL, with an additional 36 shares held indirectly through a family trust.
Colgate-Palmolive (India) stock: Steady in volatile markets—what you need to know
Colgate-Palmolive (India) is presented as a strong defensive investment for North American investors seeking stability in emerging markets, leveraging its dominant position in India's oral care sector. The company's consistent growth, strong financial health, and reliable dividends make it an attractive pick despite potential risks from competition and raw material costs. Analysts generally view the stock as a core holding with sound fundamentals, suggesting monitoring for optimal entry points due to current elevated valuations.
Clorox Adds Purell As Hygiene Reach Grows And Valuation Gap Persists
Clorox (NYSE:CLX) has acquired GOJO Industries, the maker of Purell, expanding its presence in health and hygiene solutions across consumer and B2B channels. This acquisition integrates Purell into Clorox's existing portfolio, deepening its involvement in everyday hygiene. The article highlights that Clorox shares are trading below analyst expectations and estimated fair value but also notes the company's high debt level as a key consideration for investors.
Celsius Holdings, Inc. (CELH) stock price, news, quote and history
This Yahoo Finance page provides a comprehensive overview of Celsius Holdings, Inc. (CELH), including its current stock price, recent news articles, and performance data. The stock is shown to be trading at $34.08, with recent volatility and various analyses from financial news outlets regarding its valuation, growth prospects, and market performance. The performance overview indicates a significant year-to-date decline for CELH compared to the S&P 500 benchmark.
Compagnie Lombard Odier SCmA Trims Stake in Colgate-Palmolive Company $CL
Compagnie Lombard Odier SCmA significantly reduced its stake in Colgate-Palmolive Company by 98.9% in Q4, selling 240,000 shares. Despite this, analysts maintain a "Moderate Buy" consensus with a target price of $95.19, and Colgate-Palmolive reported strong Q4 earnings, beating estimates, and increased its quarterly dividend. However, there has been significant insider selling from top executives.
Deutsche Bank upgrades Colgate-Palmolive (CL)
Deutsche Bank has upgraded Colgate-Palmolive (CL). The article, sourced from MSN, provides this key financial action without further details in the provided content.
Colgate-Palmolive Company $CL Shares Bought by Frank Rimerman Advisors LLC
Frank Rimerman Advisors LLC significantly increased its stake in Colgate-Palmolive Company (NYSE:CL) by 237.4% during Q4, holding 19,557 shares valued at $1,545,000. Other institutional investors also adjusted their positions, and analysts have provided varied ratings, with a consensus of "Moderate Buy" and a target price of $95.19. The company recently reported strong quarterly earnings, beating estimates, and increased its quarterly dividend to $0.53 per share.
What to Expect From Colgate-Palmolive’s Q1 2026 Earnings Report
Colgate-Palmolive (CL), a global consumer staples company, is set to release its Q1 2026 earnings report on Friday, April 24, with analysts predicting an adjusted EPS of $0.95, up 4.4% year-over-year. Despite lagging behind the S&P 500 in share performance over the last year and a recent downgrade from TD Cowen, analysts maintain a "Moderate Buy" consensus with a potential upside of 12.9% from current levels. The company's strong brand loyalty and consistent earnings beats are noted, with projected EPS growth for fiscal 2026 and 2027.
What to Expect From Colgate-Palmolive’s Q1 2026 Earnings Report
Colgate-Palmolive (CL) is set to release its Q1 2026 earnings, with analysts projecting an adjusted EPS of $0.95, a 4.4% increase year-over-year. Despite a recent stock downgrade and underperformance compared to the S&P 500, the company benefits from strong brand loyalty and steady demand. Analysts have a "Moderate Buy" rating for CL, with an average price target indicating a potential 12.9% upside.
Deutsche Bank Upgrades Colgate-Palmolive Company (CL) to Buy, Sees Opportunity after Selloff
Deutsche Bank has upgraded Colgate-Palmolive Company (CL) to Buy from Hold, raising its price target to $98 from $90. The firm views the recent selloff as a buying opportunity, citing Colgate's quality franchise and ability to weather volatility. Additionally, Colgate-Palmolive recently increased its quarterly common stock cash dividend to $0.53 per share and appointed Christopher Boerner to its Board of Directors.
Consumer Staples Have Been Abandoned. Colgate and 5 More Stocks Worth a Look.
The article discusses how consumer staples stocks have been overlooked by investors despite the broader market rebound. It suggests that these stocks now appear attractive and advises careful selection. Colgate is mentioned as one example, with its stock down 14% since late February.
Colgate-Palmolive Co elevates Mukul Deoras as CMO
Colgate-Palmolive Co has appointed Mukul Deoras as its new Chief Marketing Officer, a move that highlights the increasing number of Indians taking leadership roles in multinational FMCG companies. Deoras, an IIM Ahmedabad alumnus, will oversee an estimated $2-billion advertising budget, focusing on emerging markets and digital media visibility. This appointment places three Indians in top management positions at Colgate-Palmolive Co, emphasizing their strategic importance to the company.
Growth Patterns, Segment Analysis, and Competitive Approaches Influencing the Dental Preventive Supplies Market
The global dental preventive supplies market is projected to reach $6.57 billion by 2030, growing at a CAGR of 5.6% due to increased oral health awareness, product innovations, and expanding dental services. Key players like Procter & Gamble and Colgate-Palmolive are driving growth with new products, such as antibacterial oral care regimens. The market is segmented by product type, material, distribution channel, application, and end-user, reflecting diverse consumer needs.
Colgate-Palmolive Company $CL Shares Sold by PineStone Asset Management Inc.
PineStone Asset Management Inc. reduced its stake in Colgate-Palmolive (NYSE:CL) by 0.9% in the fourth quarter, selling 13,800 shares. This reduction leaves them with 1.59 million shares valued at approximately $125.7 million, making it their 26th largest holding. The article also notes significant insider selling by the company's CFO and another insider, recent strong quarterly earnings, an increased dividend, and a "Moderate Buy" consensus rating from analysts with an average price target of $95.19.
Brookstone Capital Management Has $12.54 Million Stock Holdings in Colgate-Palmolive Company $CL
Brookstone Capital Management increased its stake in Colgate-Palmolive Company by 11.1% in Q4, now holding 158,730 shares valued at $12.54 million. Other institutional investors also adjusted their positions, with institutional ownership reaching 80.41%. Colgate-Palmolive recently released strong earnings, increased its quarterly dividend, and received several "Buy" ratings from analysts with an average price target of $95.19.
Analyst cuts Colgate-Palmolive on rising input costs, slower earnings growth
TD Cowen downgraded Colgate-Palmolive (CL) to Hold from Buy due to concerns over rising input costs, particularly for oil-based components and tallow, which are expected to pressure earnings. Analyst Robert Moskow lowered the price target to $85, citing slower anticipated EPS growth for 2026 and 2027. Despite Colgate's exposure to emerging markets, the firm believes its pricing power may not be as robust as some investors perceive, leaving near-term earnings vulnerable to inflation and limited pricing flexibility in developed markets.
High Oil Prices Will Hurt Colgate-Palmolive Stock According to Wall Street
Colgate-Palmolive (CL) has been downgraded from Buy to Hold by TD Cowen due to surging oil-based input costs exacerbated by the Iran War and weak North American sales. Analyst Robert Moskow cut the price target to $85 from $96, as these cost pressures are expected to compress margins and lead to reduced earnings estimates for 2026-2027, despite solid Q4 2025 results. The stock has already seen a significant pullback, and tighter margins threaten its dividend growth streak.
Colgate-Palmolive (NYSE:CL) Earns "Hold" Rating from TD Cowen
TD Cowen has reiterated a "Hold" rating for Colgate-Palmolive (NYSE:CL), setting an $85 price target, which suggests a slight downside from its last closing price. The company received a "Moderate Buy" consensus rating from analysts with an average target price of $95.19, despite recent insider share sales totaling over $17 million. Colgate-Palmolive recently exceeded quarterly earnings and revenue estimates.
J. Safra Sarasin Holding AG Trims Stake in Colgate-Palmolive Company $CL
J. Safra Sarasin Holding AG reduced its stake in Colgate-Palmolive Company by 8.7% in the fourth quarter, selling over 64,000 shares. Despite this, institutional investors still hold a significant portion of the company, and analysts maintain a "Moderate Buy" rating with a consensus price target of $95.25. Colgate-Palmolive recently reported strong Q4 earnings, surpassing estimates, and increased its quarterly dividend.
I interviewed the CEOs of Reddit, Colgate-Palmolive, and 6 other top companies about leading for the long run. Here's what they said
The article discusses how top CEOs focus on long-term success despite pressure for immediate results, contrasting this with President Kennedy's "Moon shot" mentality. The author interviewed eight CEOs, including Noel Wallace of Colgate-Palmolive, to understand their practical approaches to conviction when outcomes are uncertain and expensive. It highlights the importance of tenacity and building structural conditions for sustained efforts.
Mn Services Vermogensbeheer B.V. Has $130.16 Million Stake in Procter & Gamble Company (The) $PG
Mn Services Vermogensbeheer B.V. significantly increased its stake in Procter & Gamble Company (NYSE:PG) during the fourth quarter, now holding 908,209 shares valued at $130.16 million, making it their 19th largest holding. This comes amidst other institutional investor activity, insider selling including by Chairman Jon Moeller, and a "Moderate Buy" consensus rating from analysts with an average price target of $167.83. Procter & Gamble also recently announced a quarterly dividend, maintaining a strong yield for investors.
Colgate-Palmolive stock downgraded by TD Cowen on inflation concerns
TD Cowen downgraded Colgate-Palmolive (NYSE:CL) to Hold from Buy and lowered its price target to $85 from $96 due to heightened inflationary pressures, particularly from oil-based inputs and tallow. The firm reduced its earnings per share estimates for 2026 and 2027, projecting lower growth than both consensus and company guidance. Despite these near-term headwinds, InvestingPro analysis suggests the stock may be undervalued relative to its Fair Value.
TD Cowen Downgrades Colgate-Palmolive Company (CL) to Hold
TD Cowen analyst Robert Moskow has downgraded Colgate-Palmolive Company (NYSE: CL) to a Hold rating. The article, published on March 31, 2026, indicates that further details are available for premium subscribers only. This suggests a shift in the analyst's outlook on the company's stock performance.
Raymond James Maintains Colgate-Palmolive (CL) Outperform Recommendation
Raymond James has reiterated its "Outperform" rating for Colgate-Palmolive (CL). The firm's analysis indicates continued confidence in the consumer staples giant's stock performance. This recommendation suggests that Raymond James expects Colgate-Palmolive to outperform the broader market.
Cramer’s Mad Dash: Colgate-Palmolive
Jim Cramer delivers his daily "Mad Dash" focusing on Colgate-Palmolive. This article is a brief prompt for a video segment where Cramer discusses his insights on the company. The content primarily features a title and a short description, indicating a video clip as the main substance.
Colgate-Palmolive (NYSE:CL) Raised to Buy at Deutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft has upgraded Colgate-Palmolive (NYSE:CL) from a "hold" to a "buy" rating, setting a $98 price target, indicating a potential 16.3% upside. This upgrade follows Colgate-Palmolive's strong quarterly performance, where it exceeded EPS and revenue expectations. Despite recent insider selling, institutional investors hold a significant majority stake in the company.
Colgate-Palmolive Co Stock Gains Momentum as Deutsche Bank Upgrades to Buy with $98 Target Amid Grow
Deutsche Bank has upgraded Colgate-Palmolive Co (NYSE:CL) to Buy from Hold, raising its price target to $98 from $90, citing the company's strong gross margins and strategic growth initiatives for 2030. This upgrade, along with a "Moderate Buy" consensus from other analysts, highlights Colgate-Palmolive's position as a stable dividend payer in the consumer staples sector. The company's focus on premiumization, data-driven innovation, and a robust global business model supports its continued financial strength and resilience against market volatility.
Dental Floss Market Is Going to Boom | 3M, Dr Wild & Co. AG, Sunstar Suisse SA, The humble Co.
The dental floss market is projected to grow from USD 727.6 million in 2026 to USD 978.9 million by 2033, exhibiting a CAGR of 6%. This growth is driven by innovation, increased investment, and changing regional dynamics, requiring strategic insights for decision-makers. The report offers detailed analysis including market segmentation, financial breakdowns of major players, and regional coverage to help stakeholders capitalize on market opportunities.
Deutsche Bank upgrades Colgate-Palmolive stock rating on growth strategy
Deutsche Bank has upgraded Colgate-Palmolive (NYSE:CL) to Buy from Hold, raising its price target to $98 due to the company's strong growth strategy and financial flexibility. Despite challenges in its North American business, Colgate-Palmolive is focusing on premiumization, innovation, and enhanced capabilities. The company, which has a history of 36 consecutive years of dividend increases, recently reported strong Q4 earnings, adjusted its operating segments, and increased its dividend.
US judge allows class action against Colgate on kids’ rinse labels – report
A US federal judge has permitted two proposed class-action lawsuits against Colgate-Palmolive regarding alleged misleading packaging for its children's mouth rinses, while dismissing a similar case concerning toothpaste. The lawsuits argue that Colgate’s colorful packaging and flavors for children’s rinses imply safety for young children, despite health guidelines recommending against fluoride rinses for those under six. The judge rejected Colgate's defense that consumers should rely on back-label FDA warnings, emphasizing that reasonable consumers might be confused by labels prominently featuring "kids" or "children's."
